Form 4: Cingulate Executive Receives Stock Grant
Insider Transaction (Form 4)
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc., reported multiple transactions in common stock on July 16, 2026.
Summary
- Grant/award: acquired 53,600 Stock Option (right to Buy) on July 16, 2026; holds 53,600 after (Direct).
- Grant/award: acquired 26,400 Stock Option (right to Buy) on July 16, 2026; holds 26,400 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Matthew Brams — Officer (EVP and Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Grant/award | Stock Option (right to Buy) | 53,600 | — | — | 53,600 |
| 2026-07-16 | Grant/award | Stock Option (right to Buy) | 26,400 | — | — | 26,400 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Grant/award (53,600 shares) |
| 2026-07-16 | Grant/award (26,400 shares) |
Keywords
insider transaction, Form 4, CING, Cingulate Inc., neutral, Matthew Brams
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.